Search

How Can We Help You?

Video

Quick Info:

Find a Doctor Specialties (800) 213-3284

Select Clinical Trial

Protocol Number: SWOG 1826 Hodgkin Lymphoma

Protocol Title: A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 18 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma.

Eligibility: Patient population age 18 years or older with newly diagnosed advanced stage Classical Hodgkin Lymphoma.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: EZH-302

Protocol Title: A Phase 1b/3 double-blind, randomized, active-controlled, 3-stage, biomarker adaptive study of tazemetostat or placebo in combination with lenalidomide plus rituximab in subjects with relapsed/refractory follicular lymphoma

Eligibility: 18 years or older who have been previously treated with at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy for follicular lymphoma and have documented relapsed, refractory, or progressive disease.

Contact Information: (910) 715-2200

 

Specialties
Clara McLean House
Make a Donation
News & Events